Our study had small sample size, thus may not be generalized to other ethnicities; hence, multicenter studies examining the association of lipid profile and serum insulin, insulin-like growth factor-1 levels with benign prostatic hyperplasia or prostate cancer are warranted. The gene discussed is INS; the disease is prostate cancer.